Inhalation Sciences receives new order worth 2.9 million SEK from returning big pharma customer
(Stockholm, 29 October, 2021) Inhalation Sciences (ISAB) has signed one of the largest purchase orders in its history with a major global pharmaceutical company. The client has previously carried out two extensive clinical research projects with Inhalation Research Services (IRS). The order is for ISAB’s aerosol R&D system PreciseInhale® and its in vitro lung simulation module DissolvIt®.The total value of the order is 299,400 KEUR (2.97 million SEK). The order follows lengthy negotiations and previous successful contract research projects for the company carried out by Inhalation Research